Immix Biopharma, Inc. IMMX Short- and long-term operating lease liabilities
Short- and long-term operating lease liabilities at other companies
Other financials
Where this comes from
Reported directly by Immix Biopharma, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOperatingLeaseLiability.
The official record: Immix Biopharma, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Immix Biopharma, Inc.'s short- and long-term operating lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Immix Biopharma, Inc.'s short- and long-term operating lease liabilities?
- Immix Biopharma, Inc. (IMMX) reported short- and long-term operating lease liabilities of -$35.23K in Q1 2026.
- How has Immix Biopharma, Inc.'s short- and long-term operating lease liabilities changed year-over-year?
- Immix Biopharma, Inc.'s short- and long-term operating lease liabilities decreased by 122.6% year-over-year, from -$15.83K to -$35.23K.